KEGG_PATHWAY |
hsa04611:Platelet activation |
10 |
7.94 |
10.58 |
2.53E-07 |
3.61E-05 |
AKT1, TLN2, STIM1, GNAS, SNAP23, PRKG1, ARHGEF12, ITPR1, ITPR2, ITGA2B |
KEGG_PATHWAY |
hsa04270:Vascular smooth muscle contraction |
8 |
6.35 |
9.41 |
1.64E-05 |
1.17E-03 |
CALD1, GNAS, PRKG1, ARHGEF12, PRKCD, ITPR1, ARHGEF11, ITPR2 |
KEGG_PATHWAY |
hsa04915:Estrogen signaling pathway |
6 |
4.76 |
8.34 |
6.44E-04 |
3.02E-02 |
AKT1, FKBP5, GNAS, PRKCD, ITPR1, ITPR2 |
KEGG_PATHWAY |
hsa04666:Fc gamma R-mediated phagocytosis |
5 |
3.97 |
8.19 |
2.89E-03 |
9.82E-02 |
AKT1, ASAP2, ASAP1, MARCKS, PRKCD |
KEGG_PATHWAY |
hsa04922:Glucagon signaling pathway |
5 |
3.97 |
6.95 |
5.21E-03 |
1.39E-01 |
AKT1, ACACA, GNAS, ITPR1, ITPR2 |
KEGG_PATHWAY |
hsa04730:Long-term depression |
4 |
3.17 |
9.17 |
8.74E-03 |
1.89E-01 |
GNAS, PRKG1, ITPR1, ITPR2 |
KEGG_PATHWAY |
hsa05205:Proteoglycans in cancer |
6 |
4.76 |
4.13 |
1.34E-02 |
2.40E-01 |
AKT1, ANK1, ARHGEF12, ITPR1, PXN, ITPR2 |
KEGG_PATHWAY |
hsa04910:Insulin signaling pathway |
5 |
3.97 |
4.98 |
1.64E-02 |
2.55E-01 |
AKT1, PRKAR2B, SLC2A4, TSC2, ACACA |
KEGG_PATHWAY |
hsa04970:Salivary secretion |
4 |
3.17 |
6.40 |
2.30E-02 |
3.09E-01 |
GNAS, PRKG1, ITPR1, ITPR2 |
KEGG_PATHWAY |
hsa04540:Gap junction |
4 |
3.17 |
6.25 |
2.44E-02 |
2.98E-01 |
GNAS, PRKG1, ITPR1, ITPR2 |
KEGG_PATHWAY |
hsa04022:cGMP-PKG signaling pathway |
5 |
3.97 |
4.35 |
2.55E-02 |
2.85E-01 |
AKT1, SLC8A2, PRKG1, ITPR1, ITPR2 |
KEGG_PATHWAY |
hsa04912:GnRH signaling pathway |
4 |
3.17 |
6.05 |
2.66E-02 |
2.75E-01 |
GNAS, PRKCD, ITPR1, ITPR2 |
KEGG_PATHWAY |
hsa04750:Inflammatory mediator regulation of TRP channels |
4 |
3.17 |
5.62 |
3.22E-02 |
3.02E-01 |
GNAS, PRKCD, ITPR1, ITPR2 |
KEGG_PATHWAY |
hsa04020:Calcium signaling pathway |
5 |
3.97 |
3.84 |
3.79E-02 |
3.26E-01 |
SLC8A2, STIM1, GNAS, ITPR1, ITPR2 |